TNYA · Tenaya Therapeutics, Inc.

$0.70 +0.02 (+2.61%)

Market Cap

$154.74M

224.23M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-06-04	Jefferies Global Healthcare Conference	Conference
2026-06-03	Interim Data from the MyPEAK-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated Hypertrophic Cardiomyopathy	Event
2026-05-15	Earnings conference call (announced in 8-K)	Earnings call
2026-05-15	Data from RIDGE-1 Phase 1b/2 Clinical Trial of TN-401 in Adults with PKP2-associated ARVC Presented at ASGCT 2026	Event
2026-03-09	Leerink Global Healthcare Conference	Conference
2025-12-11	Interim Data from RIDGE-1 Phase 1b Clinical Trial of TN-401 in Adults with PKP2-associated ARVC	Event
2025-11-10	Interim Clinical Data from MyPEAK-1 Evaluating Safety and Early Efficacy of TN-201 in Adult Patients with MYBPC3-Associated HCM	Event
2025-10-14	H.C. Wainwright Genetic Medicines Virtual Conference	Conference
2025-09-09	Morgan Stanley 23rd Annual Global Healthcare Conference	Conference
2025-08-26	Measuring Protein Expression in Cardiac Gene Therapy - KOL Webcast Event	Webcast
2025-08-12	Canaccord Genuity 45th Annual Growth Conference	Conference

Source: https://investors.tenayatherapeutics.com/

Key facts CIK 1858848 CUSIP 87990A106 13F (30d) 80 filings 80 filers Visit website Investor relations